Product category:
Liquid handling
News Release from: Tecan Group | Subject: Freedom Evo 200
Edited by the Laboratorytalk Editorial
Team on 02 August 2007
Faster lead compound ID with automated
assays
Research scientists at Nicholas Piramal India, a pharmaceutical company in Mumbai, are automating biochemical and cell-based drug discovery with a Tecan Freedom Evo 200 liquid handling workstation
This is one of the first fully functional, integrated screening facilities in India and the assays are designed to identify new lead compounds for the treatment of cancers, metabolic diseases and inflammatory disorders The Freedom Evo workstation is controlled by Tecan's Freedom Evoware Plus software, which combines pipetting and scheduling for simultaneous testing of hundreds of compounds in triplicate
This article was originally published on Laboratorytalk on 7 Jun 2007 at 8.00am (UK)
Related stories
HTS of infectious virus entry in mammalian cells
Study aims to individually silence 7000 mammalian genes using RNA interference to measure how this affects the abilities of 11 different viruses, including influenza, herpes and SV40, to infect hosts
Asha Almeida, group leader at the Nicholas Piramal Research Center, explained: "Being able to automate all the assays using a variety of different cell lines with a single platform was critical in deciding which robot to choose.
"Our current throughput is 10,000 data points per week and, in two months, we can complete a workload that would take an entire year to perform manually.
"Automating our assays using the Freedom Evo system has made life much easier and significantly reduced the hit to lead transformation time," she continued.
"In the near future, we will be able to double our data throughput by switching to a 384-well assay format.".
• Tecan Group: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
